Suppr超能文献

尼美舒利与对乙酰氨基酚治疗儿童上呼吸道炎性疾病所致发热的比较。

A comparison of nimesulide and paracetamol in the treatment of fever due to inflammatory diseases of the upper respiratory tract in children.

作者信息

Polidori G, Titti G, Pieragostini P, Comito A, Scaricabarozzi I

机构信息

Istituto di Clinica Pediatrica, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Drugs. 1993;46 Suppl 1:231-3. doi: 10.2165/00003495-199300461-00059.

Abstract

The efficacy and tolerability of nimesulide were compared with those of paracetamol in a nonblind randomised study that recruited 110 children (64 males, 46 females; aged 3 to 6 years) with inflammation of the upper respiratory tract and fever. Nimesulide suspension (1.5 mg/kg 3 times daily) or paracetamol syrup (10 mg/kg 4 times daily) were administered orally until fever resolved. Body temperature was recorded and local pain and general discomfort assessed. Three patients treated with nimesulide and 6 patients treated with paracetamol withdrew from the study as a result of adverse events, and 1 paracetamol-treated patient discontinued because of a requirement for therapy with steroids. Nimesulide was as effective as paracetamol in reducing fever, local pain, and general discomfort. Nimesulide therefore appears to be at least as effective as paracetamol in terms of antipyretic and anti-inflammatory activity in children with inflammation of the upper respiratory tract and fever.

摘要

在一项非盲法随机研究中,将尼美舒利与对乙酰氨基酚的疗效和耐受性进行了比较。该研究招募了110名患有上呼吸道炎症和发热的儿童(64名男性,46名女性;年龄3至6岁)。口服给予尼美舒利混悬液(1.5毫克/千克,每日3次)或对乙酰氨基酚糖浆(10毫克/千克,每日4次),直至发热消退。记录体温,并评估局部疼痛和全身不适情况。3名接受尼美舒利治疗的患者和6名接受对乙酰氨基酚治疗的患者因不良事件退出研究,1名接受对乙酰氨基酚治疗的患者因需要使用类固醇治疗而停药。在降低发热、局部疼痛和全身不适方面,尼美舒利与对乙酰氨基酚效果相当。因此,在患有上呼吸道炎症和发热的儿童中,就解热和抗炎活性而言,尼美舒利似乎至少与对乙酰氨基酚一样有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验